Full Text View
Tabular View
No Study Results Posted
Related Studies
Clinical Trial of Vincristine vs. Prednisolone for Treatment of Complicated Hemangiomas
This study is currently recruiting participants.
Study NCT00555464   Information provided by FDA Office of Orphan Products Development
First Received: November 7, 2007   Last Updated: January 15, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hemangioma
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Vascular Tissue
Interventions listed in this trial
Vincristine
Prednisone
Additional drug interventions recognized in this trial
Methylprednisolone
Methylprednisolone acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Sodium phosphate
More general drug interventions related to this trial
Anti-Inflammatory Agents
Antiemetics
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Antineoplastic Agents, Phytogenic
Autonomic Agents
Cathartics
Central Nervous System Agents
Gastrointestinal Agents
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Neuroprotective Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
FDA Office of Orphan Products Development
Medical College of Wisconsin
University of California, San Francisco
Indiana University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services